Trials / Terminated
TerminatedNCT00226954
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary: To determine the duration of use of zoledronic acid in improving Bone mineral density in patients with prostate cancer who are on hormones intermittently. Secondary Objectives: To describe the safety and tolerability at this dose and schedule
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zoledronic acid |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2007-11-01
- Completion
- 2009-02-01
- First posted
- 2005-09-27
- Last updated
- 2020-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00226954. Inclusion in this directory is not an endorsement.